Leukemia-Related Transcription Factor TEL Is Negatively Regulated through Extracellular Signal-Regulated Kinase-Induced Phosphorylation

REFERENCES

• Arai, H., Maki K., Waga K., Sasaki K., Nakamura Y., Imai Y., Kurokawa M., Hirai H., and Mitani K.. 2002. Functional regulation of TEL by p38-induced phosphorylation. Biochem. Biophys. Res. Commun. 299:116–125.
   PubMed Web of Science ®Google Scholar
• Brunet, A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S., Anderson M. J., Arden K. C., Blenis J., and Greenberg M. E.. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857–868.
   PubMed Web of Science ®Google Scholar
• Buijs, A., van Rompaey L., Molijn A. C., Davis J. N., Vertegaal A. C. O., Potter M. D., Adams C., van Baal S., Zwarthoff E. C., Roussel M. F., and Grosveld G. C.. 2000. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol. Cell. Biol. 20:9281–9293.
   PubMed Web of Science ®Google Scholar
• Chang, L., and Karin M.. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37–40.
   PubMed Web of Science ®Google Scholar
• Fenrick, R., Amann J. M., Lutterbach B., Wang L., Westendorf J. J., Downing J. R., and Hiebert S. W.. 1999. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol. Cell. Biol. 19:6566–6574.
   PubMed Web of Science ®Google Scholar
• Fenrick, R., Wang L., Nip J., Amann J. M., Rooney R. J., Walker-Daniels J., Crawford H. C., Hulboy D. L., Kinch M. S., Matrisian L. M., and Hiebert S. W.. 2000. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of Ras-transformed cells while repressing the transcription of stromelysin-1. Mol. Cell. Biol. 20:5828–5839.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., Barker G. F., Lovett M., and Gilliland D. G.. 1994. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307–316.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., Goga A., Barker G. F., Afar D. E., McLaughlin J., Bohlander S. K., Rowley J. D., Witte O. N., and Gilliland D. G.. 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein. Mol. Cell. Biol. 16:4107–4116.
   PubMed Web of Science ®Google Scholar
• Gu, X., Shin B. H., Akbarali Y., Weiss A., Boltax J., Oettgen P., and Libermann T. A.. 2001. Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6. J. Biol. Chem. 276:9421–9436.
   PubMedGoogle Scholar
• Guidez, F., Petrie K., Ford A. M., Lu H., Bennett C. A., MacGregor A., Hannemann J., Ito Y., Ghysdael J., Greaves M., Wiedemann L. M., and Zelent A.. 2000. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood 96:2557–2561.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., Sun W., Davis J. N., Golub T., Shurtleff S., Buijs A., Downing J., Grosveld G., Roussel M. F., Gilliland D. G., Lenny N., and Meyers S.. 1996. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16:1349–1355.
   PubMed Web of Science ®Google Scholar
• Jousset, C., Carron C., Boureux A., Quang C. T., Oury C., Dusanter-Fourt I., Charon M., Levin J., Bernard O., and Ghysdael J.. 1997. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein. EMBO J. 16:69–82.
   PubMedGoogle Scholar
• Kim, C. A., Phillips M. L., Kim W., Gingery M., Tran H. H., Robinson M. A., Faham S., and Bowie J. U.. 2001. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J. 20:4173–4182.
   PubMed Web of Science ®Google Scholar
• Kolch, W. 2000. Meaningful relationship: the regulation of the Ras/Raf/MEK/ERK pathways by protein interactions. Biochem. J. 351:289–305.
   PubMed Web of Science ®Google Scholar
• Kops, G. J. P. L., de Ruiter N. D., de Vries-Smits A. M. M., Powell D. R., Bos J. L., and Burgering B. M. T.. 1999. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398:630–634.
   PubMed Web of Science ®Google Scholar
• Kuno, Y., Abe A., Emi N., Iida M., Yokozawa T., Towatari M., Tanimoto M., and Saito H.. 2001. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p13). Blood 97:1050–1055.
   PubMed Web of Science ®Google Scholar
• Kurokawa, M., Mitani K., Yamagata T., Tanaka T., Izutsu K., Ogawa S., Moriguchi T., Nishida E., Yazaki Y., and Hirai H.. 2000. The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death. EMBO J. 19:2958–2968.
   PubMedGoogle Scholar
• Kwiatkowski, B. A., Bastian L. S., Bauer T. R., Jr., Tsai S., Zielinska-Kwiatkowska A. G., and Hickstein D. D.. 1998. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J. Biol. Chem. 273:17525–17530.
   PubMed Web of Science ®Google Scholar
• Lacronique, V., Boureux A., Valle V. D., Poirel H., Quang C. T., Mauchauffe M., Berthou C., Lessard M., Berger R., Ghysdael J., and Bernard O. A.. 1997. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309–1312.
   PubMed Web of Science ®Google Scholar
• Le Gallic, L., Sgouras D., Beal G., Jr., and Mavrothalassitis G.. 1999. Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation. Mol. Cell. Biol. 19:4121–4133.
   PubMed Web of Science ®Google Scholar
• Lopez, R. G., Carron C., Oury C., Gardellin P., Bernard O., and Ghysdael J.. 1999. TEL is a sequence-specific transcriptional repressor. J. Biol. Chem. 274:30132–30138.
   PubMed Web of Science ®Google Scholar
• Maki, K., Mitani K., Yamagata T., Kurokawa M., Kanda Y., Yazaki Y., and Hirai H.. 1999. Transcriptional inhibition of p53 by MLL/MEN chimeric protein found in myeloid leukemia. Blood 93:3216–3224.
   PubMedGoogle Scholar
• Matsuzaki, T., Aisaki K., Yamamura Y., Noda M., and Ikawa Y.. 2000. Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a Friend murine leukemia cell line. Oncogene 19:1500–1508.
   PubMed Web of Science ®Google Scholar
• Miyazaki, R., Ogata H., and Kobayashi Y.. 2001. Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation. Ann. Hematol. 80:284–291.
   PubMed Web of Science ®Google Scholar
• Pearson, G., Robinson F., Gibson T. B., Xu B. E., Karandikar M., Berman K., and Cobb M. H.. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153–183.
   PubMed Web of Science ®Google Scholar
• Poirel, H., Oury C., Carron C., Duprez E., Laabi Y., Tsapis A., Romana S. P., Mauchauffe M., Le Coniat M., Berger R., Ghysdael J., and Bernard O. A.. 1997. The TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene 14:349–357.
   PubMed Web of Science ®Google Scholar
• Potter, M. D., Buijs A., Kreider B., van Rompaey L., and Grosveld G.. 2000. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6. Blood 95:3341–3348.
   PubMedGoogle Scholar
• Rabault, B., Roussel M. F., Quang C. T., and Ghysdael J.. 1996. Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene 13:877–881.
   PubMedGoogle Scholar
• Slupsky, C. M., Gentile L. N., Donaldson L. W., Mackereth C. D., Seidel J. J., Graves B. J., and McIntosh L. P.. 1998. Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. Proc. Natl. Acad. Sci. USA 95:12129–12134.
   PubMed Web of Science ®Google Scholar
• Tanaka, T., Kurokawa M., Ueki K., Tanaka K., Imai Y., Mitani K., Okazaki K., Sagata N., Yazaki Y., Shibata Y., Kadowaki T., and Hirai H.. 1996. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell. Biol. 16:3967–3979.
   PubMed Web of Science ®Google Scholar
• Ueki, K., Matsuda S., Tobe K., Gotoh Y., Tamemoto H., Yachi M., Akanuma Y., Yazaki Y., Nishida E., and Kadowaki T.. 1994. Feedback regulation of mitogen-activated protein kinase kinase activity of c-Raf-1 by insulin and phorbol ester stimulation. J. Biol. Chem. 269:15756–15761.
   PubMedGoogle Scholar
• Van Rompaey, L., Potter M., Adams C., and Grosveld G.. 2000. Tel induces a G1 arrest and suppresses Ras-induced transformation. Oncogene 19:5244–5250.
   PubMedGoogle Scholar
• Waga, K., Nakamura Y., Maki K., Arai H., Yamagata T., Sasaki K., Kurokawa M., Hirai H., and Mitani K.. 2003. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. Oncogene 22:59–68.
   PubMedGoogle Scholar
• Wang, L., and Hiebert S. W.. 2001. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene 20:3716–3725.
   PubMed Web of Science ®Google Scholar
• Wang, L. C., Kuo F., Fujiwara Y., Gilliland D. G., Golub T. R., and Orkin S. H.. 1997. Yolk sac angiogenesis defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16:4374–4383.
   PubMed Web of Science ®Google Scholar
• Wang, L. C., Swat W., Fujiwara Y., Davidson L., Visvader J., Kuo F., Alt F. W., Gilliland D. G., Golub T. R., and Orkin S. H.. 1998. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 12:2392–2402.
   PubMed Web of Science ®Google Scholar
• Witt, O., Sand K., and Pekrun A.. 2000. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95:2391–2396.
   PubMed Web of Science ®Google Scholar
• Yang, B. S., Hauser C. A., Henkel G., Colman M. S., van Beveren C., Stacey K. J., Hume D. A., Maki R. A., and Ostrowski M. C.. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538–547.
   PubMed Web of Science ®Google Scholar
• Yang, S. H., Galanis A., and Sharrocks A. D.. 1999. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol. Cell. Biol. 19:4028–4038.
   PubMedGoogle Scholar